Mostrar el registro sencillo del ítem
| dc.contributor.author | Vera, R | |
| dc.contributor.author | Aparicio, J | |
| dc.contributor.author | Carballo-Álvarez, Luis-Fernando | |
| dc.contributor.author | Esteva, M | |
| dc.contributor.author | González-Flores, E | |
| dc.contributor.author | Santianes, J | |
| dc.contributor.author | Santolaya, F | |
| dc.contributor.author | Fernández-Cebrián, J-M | |
| dc.date.accessioned | 2026-02-12T12:19:51Z | |
| dc.date.available | 2026-02-12T12:19:51Z | |
| dc.date.issued | 2019-10 | |
| dc.identifier.citation | Vera R, Aparicio J, Carballo F, Esteva M, González-Flores E, Santianes J, et al. Recommendations for follow-up of colorectal cancer survivors. Clin Transl Oncol. octubre de 2019;21(10):1302-11. | |
| dc.identifier.issn | 1699-048X | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/24459 | |
| dc.description.abstract | Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment. | |
| dc.language.iso | eng | |
| dc.publisher | SPRINGER INTERNATIONAL PUBLISHING AG | |
| dc.rights | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | * |
| dc.subject.mesh | Antineoplastic Agents/adverse effects | |
| dc.subject.mesh | Cancer Survivors | |
| dc.subject.mesh | Carcinoembryonic Antigen/analysis | |
| dc.subject.mesh | Colonic Neoplasms/diagnosis/pathology/therapy | |
| dc.subject.mesh | Colonoscopy | |
| dc.subject.mesh | Continuity of Patient Care | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Liver Neoplasms/diagnostic imaging/secondary | |
| dc.subject.mesh | Lung Neoplasms/diagnostic imaging/secondary | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Neoplasm Recurrence, Local/diagnosis/prevention & control | |
| dc.subject.mesh | Neoplasm Staging | |
| dc.subject.mesh | Oxaliplatin/adverse effects | |
| dc.subject.mesh | Patient Care Team | |
| dc.subject.mesh | Population Surveillance | |
| dc.subject.mesh | Postoperative Complications | |
| dc.subject.mesh | Primary Prevention | |
| dc.subject.mesh | Radiotherapy/adverse effects | |
| dc.subject.mesh | Rectal Neoplasms/diagnosis/pathology/therapy | |
| dc.subject.mesh | Secondary Prevention | |
| dc.subject.mesh | Sexual Dysfunction, Physiological/etiology | |
| dc.subject.mesh | Time Factors | |
| dc.title | Recommendations for follow-up of colorectal cancer survivors | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 30762206 | |
| dc.relation.publisherversion | http://link.springer.com/10.1007/s12094-019-02059-1 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1007/s12094-019-02059-1 | |
| dc.journal.title | Clinical & Translational Oncology | |
| dc.identifier.essn | 1699-3055 |